# Trade Mark Journal No.2025/049 5 December 2025

## WO0000001887341 (5,42)

Office of origin: United States of America

Date of International Registration:14 October 2025
Date of designation in the UK: 14 October 2025

The mark consists of a design resembling a vortex comprised of circles of different sizes, with the words SUPERLUMINAL MEDICINES appearing to the right of the design, with the word SUPERLUMINAL appearing above the word MEDICINES and four circles above the letter "M" and next to the dot in the letter "i" in SUPERLUMINAL.

International priority date claimed: 29 August 2025 (United States of America) (99365859)

Class 5
  Pharmaceutical agents modulating high value protein targets such as G protein coupled receptors.
Class 42
  Development of pharmaceutical preparations and medicines.

Superluminal Medicines, Inc.

Representative: Gregory B. Coy Taft Stettinius & Hollister LLP, One Indiana Square, Suite 3500, Indianapolis IN 46204, UNITED STATES OF AMERICA